Niraparib in Tumors Metastatic to the CNS
Niraparib in Tumors Metastatic to the CNS
Active, not recruiting · NCT04992013 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Niraparib in Tumors Metastatic to the CNS | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, central nervous system cancer, metastatic malignant neoplasm, neoplasm, nervous system disorder | Active, not recruiting | Phase 2 | 2026-07-21 | NCT04992013 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital Cancer Center | Boston | United States | 178 |